Leadership
Ralph T. Salvagno, MD
Co-Founder, Chief Executive Officer
Dr. Salvagno is responsible for the growth and development of Extensor Bio. Dr. Salvagno trained as an orthopaedic surgeon at Case Western Reserve University/ University Hospitals of Cleveland and served his Maryland community for greater than 30 years. He previously served as CEO of a public pharma company and was responsible for soliciting investment and business development. He has extensive experience in business planning as well as clinical trial supervision. He has served as principal investigator is several phase II clinical studies and as a medical advisor to several biomedical start-ups. Dr. Salvagno served as Chief of Staff at Meritus Medical Center, Hagerstown Md. from 2017-2019 and as member of the Board of Directors of the Meritus Health System from 2017-2022.
Andre van Wijnen, PhD
Co-Founder, Chief Science Officer
Dr. van Wijnen is responsible for the design and implementation of strategies for mechanism based therapies in Dupuytren’s Disease. He has extensive experience in patient-oriented translational research projects that focus on joint health and function. His fundamental research interests encompass fundamental biomedical questions related to cell growth, differentiation and function in multiple physiological and pathological contexts, including orthopedic disorders, skeletal development and cancer.
Bruce Harmon
Chief Financial Officer
Mr. Harmon has 40 years’ experience as CFO, director and/or audit chairman of public and private companies. Since 1993, he has operated his own consulting firm where he has served as an interim officer and/or director of various public companies during their growth stages. He has worked with a pharmaceutical company with the registration of an OTC product and the negotiation of the sale of the company to a large pharma company. He has taken 15 companies public on a contract basis.